Linda Fredriksson

2.8k total citations · 1 hit paper
25 papers, 2.1k citations indexed

About

Linda Fredriksson is a scholar working on Cancer Research, Epidemiology and Neurology. According to data from OpenAlex, Linda Fredriksson has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Linda Fredriksson's work include Acute Ischemic Stroke Management (9 papers), Protease and Inhibitor Mechanisms (9 papers) and Barrier Structure and Function Studies (6 papers). Linda Fredriksson is often cited by papers focused on Acute Ischemic Stroke Management (9 papers), Protease and Inhibitor Mechanisms (9 papers) and Barrier Structure and Function Studies (6 papers). Linda Fredriksson collaborates with scholars based in Sweden, United States and Belgium. Linda Fredriksson's co-authors include Ulf Eriksson, Hong Li, Xuri Li, Daniel A. Lawrence, Hong Li, Christer Betsholtz, Johanna Andræ, Kristian Pietras, Enming J. Su and Christina Fieber and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Linda Fredriksson

24 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The PDGF family: four gene products form five dimeric isoforms

2004 608 citations Linda Fredriksson, Hong Li et al. Cytokine & Growth Factor Reviews profile →

Peers

Linda Fredriksson

EPIDE

NEURO

ONCOL

Stephen Lee United States

Magali Saint‐Geniez United States

R Gallini Sweden

Toyohiro Tada Japan

Piotr Religa Sweden

Angelina Felici Italy

Dzung H. Dinh United States

Tata Nageswara Rao United States

George Kontogeorgos Greece

Stanley A. Vinores United States

Stephen Lee United States

Linda Fredriksson

948 ×1.1

220 ×0.5

242 ×0.7

EPIDE

129 ×0.4

NEURO

186 ×0.6

ONCOL

Citations per year, relative to Linda Fredriksson Linda Fredriksson (= 1×) peers Stephen Lee

Countries citing papers authored by Linda Fredriksson

Since Specialization

Citations

This map shows the geographic impact of Linda Fredriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Fredriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Fredriksson more than expected).

Fields of papers citing papers by Linda Fredriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Fredriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Fredriksson. The network helps show where Linda Fredriksson may publish in the future.

Co-authorship network of co-authors of Linda Fredriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Fredriksson. A scholar is included among the top collaborators of Linda Fredriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Fredriksson. Linda Fredriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeitelhofer, Manuel, Christina Stefanitsch, Daniel Torrente, et al.. (2025). PDGFRα inhibition reduces myofibroblast expansion in the fibrotic rim and enhances recovery after ischemic stroke. Journal of Clinical Investigation. 135(5).

Jakobsson, Lars, et al.. (2024). Analysis of ischemic stroke-mediated effects on blood–brain barrier properties along the arteriovenous axis assessed by intravital two-photon imaging. Fluids and Barriers of the CNS. 21(1). 35–35. 5 indexed citations

Torrente, Daniel, Enming J. Su, Linda Fredriksson, et al.. (2022). Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke. Translational Stroke Research. 13(5). 801–815. 17 indexed citations

Zeitelhofer, Manuel, Milena Z. Adzemovic, Christine Moessinger, et al.. (2020). Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier. Scientific Reports. 10(1). 22383–22383. 52 indexed citations

Su, Enming J., Chunzhang Cao, Linda Fredriksson, et al.. (2017). Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathologica. 134(4). 585–604. 84 indexed citations

Lewandowski, Sebastian A., Linda Fredriksson, Daniel A. Lawrence, & Ulf Eriksson. (2016). Pharmacological targeting of the PDGF-CC signaling pathway for blood–brain barrier restoration in neurological disorders. Pharmacology & Therapeutics. 167. 108–119. 37 indexed citations

Su, Enming J., Linda Fredriksson, Shannon J. Moore, et al.. (2015). Imatinib treatment reduces brain injury in a murine model of traumatic brain injury. Frontiers in Cellular Neuroscience. 9. 385–385. 39 indexed citations

Lewandowski, Sebastian A., Ingrid Nilsson, Linda Fredriksson, et al.. (2015). Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration. Acta Neuropathologica. 131(3). 453–464. 34 indexed citations

Stefanitsch, Christina, et al.. (2015). tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations. Frontiers in Cellular Neuroscience. 9. 456–456. 9 indexed citations

10.

Fredriksson, Linda, Enming J. Su, Shannon J. Moore, et al.. (2015). Identification of a neurovascular signaling pathway regulating seizures in mice. Annals of Clinical and Translational Neurology. 2(7). 722–738. 37 indexed citations

11.

Fredriksson, Linda, Ingrid Nilsson, Enming J. Su, et al.. (2012). Platelet-Derived Growth Factor C Deficiency in C57BL/6 Mice Leads to Abnormal Cerebral Vascularization, Loss of Neuroependymal Integrity, and Ventricular Abnormalities. American Journal Of Pathology. 180(3). 1136–1144. 32 indexed citations

12.

Su, Enming J., Linda Fredriksson, Gerald P. Schielke, Ulf Eriksson, & Daniel A. Lawrence. (2009). Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke. Journal of Thrombosis and Haemostasis. 7. 155–158. 30 indexed citations

13.

Ehnman, Monika, et al.. (2008). The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth. Oncogene. 28(4). 534–544. 17 indexed citations

14.

Eitner, Frank, Claudia van Roeyen, Uta Kunter, et al.. (2008). PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis. Journal of the American Society of Nephrology. 19(2). 281–289. 97 indexed citations

15.

Su, Enming J., Linda Fredriksson, Melissa Geyer, et al.. (2008). Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nature Medicine. 14(7). 731–737. 359 indexed citations

16.

Fredriksson, Linda, Monika Ehnman, Christina Fieber, & Ulf Eriksson. (2005). Structural Requirements for Activation of Latent Platelet-derived Growth Factor CC by Tissue Plasminogen Activator. Journal of Biological Chemistry. 280(29). 26856–26862. 46 indexed citations

17.

Fredriksson, Linda, Hong Li, & Ulf Eriksson. (2004). The PDGF family: four gene products form five dimeric isoforms. Cytokine & Growth Factor Reviews. 15(4). 197–204. 608 indexed citations breakdown →

18.

Fredriksson, Linda, Hong Li, Christina Fieber, Xuri Li, & Ulf Eriksson. (2004). Tissue plasminogen activator is a potent activator of PDGF‐CC. The EMBO Journal. 23(19). 3793–3802. 148 indexed citations

19.

Li, Hong, Linda Fredriksson, Xuri Li, & Ulf Eriksson. (2003). PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 22(10). 1501–1510. 124 indexed citations

20.

Eriksson, Jan W., T Bremell, Björn Eliasson, et al.. (1998). Successful Treatment With Plasmapheresis, Cyclophosphamide, and Cyclosporin A in Type B Syndrome of Insulin Resistance: Case report. Diabetes Care. 21(8). 1217–1220. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact